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Glucose is a key biomedical analyte, especially relevant to the management of diabetes. Current methods for
glucose determination rely on the enzyme glucose oxidase, requiring specialist instrumentation and suffering
from redox-active interferents. In a new approach, a powerful and highly selective achiral glucose receptor is
mixed with a sample, L-glucose is added, and the induced CD spectrum is measured. The CD signal results
from competition between the enantiomers, and is used to determine the D-glucose content. The
involvement of L-glucose doubles the signal range from the CD spectrometer and allows sensitivity to be
adjusted over a wide dynamic range. It also negates medium effects, which must be equal for both
enantiomers. The method has been demonstrated with human serum, pre-filtered to remove proteins,
giving results which closely match the standard biochemical procedures, as well as a cell culture medium
and a beer sample containing high (70 mM) and low (0.4 mM) glucose concentrations respectively.Introduction
The determination of glucose concentrations is one of the most
important analytical problems in chemistry.1 More than 400
million people around the world are affected by diabetes.
Around 10% are Type 1, who depend on injected insulin and
must determine their blood glucose levels several times each
day. Type 2 diabetics (the remaining 90%) also require regular
blood glucose analyses. There is need both for portable, routine
measurement methods and for accurate laboratory-based
techniques. Current methodology is based, almost exclusively,
on measuring the rate of glucose oxidation catalysed by the
enzyme glucose oxidase.1d,e Although very well-developed, it
suffers from interference by redox-active species (e.g. ascorbic
acid and paracetamol2), requires specialist equipment and
tends to lose accuracy at low glucose concentrations. Alterna-
tives based on glucose receptors have been intensively studied,1a
and are beginning to make headway. For example, carbohydrate
recognition by boronic acids is well-known,3 and has been
exploited in an FDA-approved implantable glucose monitor.4
However, designing boron-based receptors showing high
selectivity for specic substrates remains challenging. Recep-
tors employing non-covalent interactions have been reported by
ourselves5 and others,6 but have tended to show low affinities
and interference from non-carbohydrate substrates. The lectin, Cantock's Close, Bristol BS8 1TS, UK.
tral, Albert Road, Bristol BS2 0XJ, UK
(ESI) available: Experimental details,
d titration analysis curves. See DOI:
f Chemistry 2020concanavalin A has also been exploited,7 but even this natural
receptor shows low selectivity for glucose.8
We recently described a glucose receptor 1 (Fig. 1a) with
remarkable properties.9 The design is based on the previously-
studied “temple” architecture,5 but features C3 symmetry and
bis-urea “pillars”, preorganised for binding to vicinal OR
groups. The affinity of 1 for glucose in water, at 18 000 M1, is
100 times higher than any previous designs, and compares
well with natural systems. Selectivity for glucose is outstanding.
Of all carbohydrates tested, only a few with all-equatorial
substitution patterns showed signicant binding. Gluco-
se : galactose selectivity, for example, was 130 : 1, while selec-
tivity for glucose vs. fructose (oen a good substrate for boron-
based receptors1a) was 360 : 1. Binding to a range of other
relevant small molecules (e.g. amino acids, nucleobases, para-
cetamol, ascorbic acid10) was undetectable. Affinities were
unaffected by changes in pH, and only slightly lowered in bio-
logical media. Given this performance, receptor 1 has clear
potential for application in glucose analysis, provided read-out
methodology can be developed. Here we show how 1 can be
exploited directly in laboratory-based (as opposed to portable)
procedures for glucose determination in complex real-world
samples. The methodology requires standard, non-specialist
equipment and features adjustable sensitivity, allowing
measurements over a wide range of glucose concentrations.Results and discussion
The application of 1 to practical glucose sensing required the
resolution of two issues. First, we needed a straightforward
means of detecting binding, compatible with complexChem. Sci., 2020, 11, 3223–3227 | 3223
Fig. 1 (a) Biomimetic glucose receptor 1, with D- and L-glucose substrates. (b) Model of 1 binding D-glucose D2 (shown as pale green). The bis-
ureido-benzenecarboxamido chromophores adopt twisted orientations in the complex. Polycarboxylate side chains are omitted for clarity. For
details of modelling see ref. 9.
Fig. 2 Predicted CD signals q from addition of (chiral) D2 to achiral,
light-absorbing 1 in the presence of L2 at varying concentrations.
Curves are derived from eqn (1), with constant k set arbitrarily to 20. (a)
Glucose concentrations relevant to blood samples. (b) Higher
concentrations relevant to fermentation samples.

























































































View Article Onlinebiological media. Second, we had to control sensitivity to allow
measurements at relevant concentrations. Here, the high
affinities shown by 1 worked against us. Normal blood glucose
concentrations are 6 mM, while the range of interest for dia-
betics is from 2 mM (dangerously low) to$12 mM (dangerously
high). For other applications concentrations may be still higher
(for example, up to 1 M for fermentation broths11). Receptor 1 is
97% saturated at [glucose] ¼ 2 mM,12 so is almost unaffected by
concentration changes above this level.
To solve both problems, we turned to circular dichroism
(CD). This technique is especially suitable for monitoring
carbohydrate recognition because saccharide substrates are
chiral but do not contain chromophores. Their inuence on
receptors, which are usually achiral and light-absorbing, is thus
easy to detect.13 Receptor 1 contains bis-ureido-
benzenecarboxamido units (coloured red in Fig. 1a) which
absorb light with lmax 260 nm. As shown in Fig. 1b, binding to
glucose was expected to cause twisting of these chromophores,
leading to strong CD signals.
A further advantage of CD detection, not previously exploi-
ted, is that the response can be tuned, and the signal range
expanded, by adding the antipode of the substrate. For example,
in the case of 1, L-glucose L2 will compete for the binding site
with D-glucose D2 on equal terms. Addition of excess L-glucose
will generate the CD spectrum of the complex 1$L2. Increasing
amounts of D-glucose will then reduce the intensity of the
spectrum, nullify exactly at [D2] ¼ [L2], then generate spectra of
opposite sign. Because the signal passes from negative to
positive, the spread of values is double that given by simple D2
addition. If the receptor is saturated throughout, a good
assumption in the present case, it is readily shown that the CD
signal q is given by eqn (1):14





Here k is a constant dependent on wavelength, path length,
instrument etc., and [1]t, [D2]t, and [L2]t, are total3224 | Chem. Sci., 2020, 11, 3223–3227concentrations of receptor, D-glucose and L-glucose in bound
and unbound forms. Note that the affinity of 1 for D2/L2 does
not appear in the equation. Provided the receptor is saturated
the binding constant is irrelevant, so that minor changes due to
medium etc. are unimportant. Predicted CD output curves for
four widely varying [L2]t (2, 8, 50 and 400 mM) are shown in
Fig. 2. In all cases the slopes are highest for low [D-glucose], but
the curves for higher [L2]t are clearly more suitable for deter-
minations in the higher concentration ranges (and vice versa).
Indeed, it can be shown that for a given [D2]t, the slope vq/v[D2]tThis journal is © The Royal Society of Chemistry 2020

























































































View Article Onlinepasses through a maximum at [D2]t ¼ [L2]t (see ESI†). This
provides a simple rule for optimising sensitivity; for maximum
response around a certain D-glucose concentration, a similar
concentration of L-glucose should be added such that measured
q is close to zero. Fig. 2 highlights the wide dynamic range of the
method. In principle, measurements can be made at any
concentration in the low millimolar range and above.
To establish the practicality of this approach, we rst needed
to show that addition of glucose to 1 produced a substantial CD
signal. D2 was titrated into a solution of 1 (0.25 mM) in aqueous
phosphate buffer15 to give the series of CD spectra shown in
Fig. 3a. The changes were monitored at 260 nm and analysed to
give a binding constant Ka of 17 200 M
1, consistent with other
methods9 (Fig. 3b). As expected, addition of L2 to 1 produced
a similar but opposite CD response (Fig. S2†), while titration of
D2 into 1$L2 caused attenuation of the CD spectrum, with
reduction to baseline when [D2]t ¼ [L2]t, followed by inversion
of the spectrum at higher [D2] (Fig. S3†).
We next considered applying the method to real-world bio-
logical samples. As mentioned earlier, we had previously tested
receptor 1 against a variety of potential substrates and observed
remarkable selectivity for glucose. Interferences from other
small molecules were therefore not expected. The affinity of 1
for glucose had been found to be somewhat affected by the
medium – for example, in cell culturemedia containing divalent
metal ions, Ka was reduced to 5300 M1. However, as the
method involves competition between D and L-glucose such
effects need not be important. Even at these lower affinities the
receptor should be nearly saturated at relevant glucoseFig. 3 (a) CD spectra from the titration of D-glucose into 1 (0.25 mM)
in aqueous phosphate buffer (10 mM, pH ¼ 7.4). Cell path length ¼
0.1 cm, 16 scans accumulated at each concentration. (b) Curve-fitting
analysis of the CD signal at 260 nm, assuming a 1 : 1 binding model. Ka
¼ 17 200 M1.
This journal is © The Royal Society of Chemistry 2020concentrations, and deviations from eqn (1) should be small. A
further potential issue was background CD absorption from
samples of practical interest. Indeed, CD spectra of human
serum contained strong signals with sharply irregular struc-
tures, presumably due to the high protein content (Fig. S4†).
However, ltration through 10 000 molecular weight cut-off
(MWCO) membranes, a quick and easy process, gave solu-
tions with negligible CD absorption (see Fig. 4). Addition of
receptor 1 to these ltered samples gave the CD spectra ex-
pected for 1$D2, formed from 1 + serum D-glucose. Treatment of
serum with glucose oxidase and catalase (to remove glucose),
ltration and addition of 1 resulted in a minimal CD signal
(Fig. 4). Titration of D-glucose into this solution15 then gave
spectra, similar to those in Fig. 3a, which were analysed to give
Ka ¼ 10 300 M1, consistent with earlier ITC measurements
performed in similar media (Fig. S6†).
With these results in hand, we were positioned to develop
methods to measure D-glucose levels in serum. To aid sample
manipulation and ensure consistency, the serum was routinely
diluted by 50% with 20 mM phosphate buffer (pH 7.4) con-
taining 1 and L-glucose as necessary.15 Measured D-glucose
levels were then doubled to give the values in the original
sample.
In a rst experiment, receptor 1 was added to ltered diluted
serum, still containing the endogenous D-glucose, and the CD
spectrum was monitored while serum containing L-glucose was
titrated into the solution.15 The CD signal was found to pass
through zero for [L2] in the range 2.85–2.95 mM, equivalent to
5.7–5.9 mM in the serum (Fig. S7†). For comparison, the serum
D-glucose concentration was also measured using an enzyme-
based YSI analyser, and found to be 5.8 mM  0.1 mM. The
YSI instrument is the standard equipment for laboratory
glucose analysis and commonly used as a reference in studies of
blood glucose monitors.16
To establish a more convenient procedure, we performed
calibration experiments as follows. Glucose-free serum was
prepared by the glucose oxidase/catalase method described
above. L-Glucose (2 mM or 8 mM) and receptor 1 (0.25 mM) were
added, with dilution, to give a titrand. A titrant containing the
same concentrations of L2 and 1, with the addition of D-glucoseFig. 4 CD spectra of: 10 000 MWCO-filtered human serum (red);
filtered serum + receptor 1 (0.25 mM) (green); filtered serum treated
with glucose oxidase (glucose-free serum, orange); filtered serum
treated with glucose oxidase + receptor 1 (0.25 mM) (purple).
Chem. Sci., 2020, 11, 3223–3227 | 3225

























































































View Article Online(40 mM), was prepared and added to the titrand. CD spectra
were acquired, corresponding to [D2] up to10 mM at constant
concentrations of 1 and L2. The spectra obtained for [L2] ¼
2 mM are shown in Fig. 5a. This set of data provides an
empirical calibration curve allowing measurement of [D2] from
single CD spectra using the given spectrometer and settings,
[L2] and [1].
More usefully, it was found that the variations in CD
absorption at 260 nm (q260) gave an excellent t to eqn (1) if k
was allowed to vary (Fig. 5b). This conrmed the validity of eqn
(1),17 while also providing an accurate value of k. Once k has
been determined, it is thus possible to obtain [D2] from a single
measurement of q260 simply by applying eqn (2), obtained by









The optimised protocol thus involves (a) centrifugal ltra-
tion of the sample through a 10k MWCO membrane, (b) dilu-
tion by 50% with a standard solution of 1 and L2 in phosphate
buffer, adjusted to give the concentrations used for the cali-
bration experiment, (c) measurement of the CD signal at
260 nm, and (d) application of eqn (2), doubling the initial
answer to account for the dilution. The procedure was applied
to the ltered serum in six independent experiments, threeFig. 5 (a) CD spectra from the titration of D-glucose into filtered,
diluted, glucose-free human serum, in the presence of L-glucose (2
mM) and 1 (0.25 mM). (b) Curve-fitting of the CD signal at 260 nm to
eqn (1) with variation of constant k. The best fit (red diamonds) was
obtained for k ¼ 76 800 mdeg M1.
3226 | Chem. Sci., 2020, 11, 3223–3227employing [L2] ¼ 2 mM and three with [L2] ¼ 8 mM. Results
varied from 5.58 to 5.87 mM, with an average of 5.75. Further
experiments would be needed to optimise the procedure and
dene the accuracy more precisely, but these initial results
suggest a similar performance to the industry-standard YSI
analyser.
To demonstrate the versatility of the method we performed
analyses in two further media. Firstly we employed a cell culture
medium, which would typically contain quite high glucose
concentrations requiring correspondingly high [L2].11 The
medium was obtained glucose-free, receptor 1 was added, and
a calibration curve was measured in the presence of L-glucose
(50 mM) as described above for the glucose-free serum. Addi-
tion of D-glucose caused the expected changes to the CD spec-
trum, which again tted well to eqn (1) (Fig. S10†). A sample for
analysis was then prepared by adding D-glucose (70 mM) to the
cell culture medium and subjected to the standard protocol
with [L2] ¼ 50 mM (see ESI†). The results were within 2% of the
expected value (Table S5†). Secondly, to illustrate the applica-
tion to samples with lower [D2], we employed beer with an
articially reduced glucose concentration.18 As described in the
ESI,† the D-glucose was rst removed enzymatically from the
beer, and a calibration curve was measured in the presence of
0.2 mM L-glucose. In this case eqn (1) did not apply, as expected
for such a low [L2], but the data could be tted to an empirical
equation in Excel (Fig. S11†). The sample for analysis was
generated by addition of D-glucose (0.4 mM) to the glucose-free
beer, and subjected to the standard protocol with [L2] ¼
0.2 mM. D-Glucose concentrations could be obtained by solving
the empirical equation. Again, the results were within 2% of
those expected (Table S6†).
Conclusions
In conclusion, we have shown that hexaurea receptor 1 can be
applied to the accurate analysis of D-glucose concentrations in
complex biological mixtures. The extreme selectivity observed
for 1 implies that interferences will be negligible. Unusually, the
sensitivity is adjustable so that samples of widely different
concentrations can be handled with ease. In terms of equip-
ment, the procedure requires only a centrifuge and a CD spec-
trometer, multi-purpose instruments that are available in many
(bio)chemical laboratories. The technique could thus comple-
ment the standard methods based on glucose oxidase, for cases
where redox-active species can cause interference and/or
specialist instrumentation may not be available.
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A. P. Davis, J. Jiménez-Barbero, A. Romero, R. Roy,
K. Smetana and H. J. Gabius, Biochim. Biophys. Acta, Gen.
Subj., 2015, 1850, 186–235; J. Arnaud, A. Audfray and
A. Imberty, Chem. Soc. Rev., 2013, 42, 4798–4813; M. Mazik,
RSC Adv., 2012, 2, 2630–2642; Y. Nakagawa and Y. Ito,
Trends Glycosci. Glycotechnol., 2012, 24, 1–12; A. P. Davis
and R. S. Wareham, Angew. Chem., Int. Ed., 1999, 38, 2978–
2996.
7 For example: S. Mansouri and J. S. Schultz, Nat. Biotechnol.,
1984, 2, 885–890; R. J. Russell, M. V. Pishko, C. C. Gefrides,
M. J. McShane and G. L. Cote, Anal. Chem., 1999, 71, 3126–
3132; B. M. Cummins, J. T. Garza and G. L. Cote, Anal.
Chem., 2013, 85, 5397–5404.This journal is © The Royal Society of Chemistry 20208 E. J. Toone, Curr. Opin. Struct. Biol., 1994, 4, 719–728.
9 R. A. Tromans, T. S. Carter, L. Chabanne, M. P. Crump, H. Li,
J. V. Matlock, M. G. Orchard and A. P. Davis, Nat. Chem.,
2019, 11, 52–56.
10 Paracetamol and ascorbic acid are known to interfere with
the standard enzyme-based methodology. See, for example:
G. Palleschi, M. A. N. Rahni, G. J. Lubrano, J. N. Ngwainbi
and G. G. Guilbault, Anal. Biochem., 1986, 159, 114–121;
A. Basu, M. Q. Slama, W. T. Nicholson, L. Langman,
T. Peyser, R. Carter and R. Basu, J. Diabetes Sci. Technol.,
2017, 11, 936–941.
11 Y.-H. Chang, K.-S. Chang, C.-Y. Chen, C.-L. Hsu, T.-C. Chang
and H.-D. Jang, Fermentation, 2018, 4, 45.
12 This generalisation presumes a low concentration of
receptor so that the glucose is in large excess. In practice it
is true for [1] # 0.25 mM.
13 Selected examples: S. Saha, B. Kauffmann, Y. Ferrand and
I. Huc, Angew. Chem., Int. Ed., 2018, 57, 13542–13546;
T. Wu, J. Prusa, J. Kessler, M. Dracinsky, J. Valenta and
P. Bour, Anal. Chem., 2016, 88, 8878–8885; Y. Ohishi,
H. Abe and M. Inouye, Chem.–Eur. J., 2015, 21, 16504–
16511; A. Schmitt, O. Perraud, E. Payet, B. Chatelet,
B. Bousquet, M. Valls, D. Padula, L. Di Bari, J. P. Dutasta
and A. Martinez, Org. Biomol. Chem., 2014, 12, 4211–4217;
G. Fukuhara and Y. Inoue, J. Am. Chem. Soc., 2011, 133,
768–770; W. Cai, G. T. Wang, P. Du, R. X. Wang,
X. K. Jiang and Z. T. Li, J. Am. Chem. Soc., 2008, 130,
13450–13459; H. Goto, Y. Furusho and E. Yashima, J. Am.
Chem. Soc., 2007, 129, 9168–9174; M. Inouye, M. Waki and
H. Abe, J. Am. Chem. Soc., 2004, 126, 2022–2027;
Y. Kikuchi, K. Kobayashi and Y. Aoyama, J. Am. Chem. Soc.,
1992, 114, 1351–1358; K. Tsukagoshi and S. Shinkai, J. Org.
Chem., 1991, 56, 4089–4091.
14 For a derivation, see Supporting Information.†.
15 Titrant and titrand solutions were prepared such that they
were identical except for the glucose added to the titrant.
Thus, aside from [D2] or [L2], no other concentrations
changed during the titrations.
16 For example, see: T. Bailey, L. J. Klaff, J. F. Wallace,
C. Greene, S. Pardo, B. Harrison and D. A. Simmons,
Diabetes, 2015, 64, A239.
17 Note that deviations from eqn (1) are expected if receptor
saturation is compromised, either by low glucose
concentrations or by medium effects lowering affinities. In
such cases the method can still be used but an empirical
calibration curve should be employed.
18 Preliminary measurements on the beer (Peroni gluten-free)
suggested that the original D-glucose concentration was
4 mM, too high for our purpose.Chem. Sci., 2020, 11, 3223–3227 | 3227
